Ernst von Dobschuetz
Overview
Explore the profile of Ernst von Dobschuetz including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
26
Citations
380
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Neumann H, Young Jr W, Krauss T, Bayley J, Schiavi F, Opocher G, et al.
Endocr Relat Cancer
. 2018 May;
25(8):T201-T219.
PMID: 29794110
Although the authors of the present review have contributed to genetic discoveries in the field of pheochromocytoma research, we can legitimately ask whether these advances have led to improvements in...
2.
Krauss T, Ferrara A, Links T, Wellner U, Bancos I, Kvachenyuk A, et al.
Endocr Relat Cancer
. 2018 May;
25(9):783-793.
PMID: 29748190
Pancreatic neuroendocrine tumors (PanNETs) are rare in von Hippel-Lindau disease (VHL) but cause serious morbidity and mortality. Management guidelines for VHL-PanNETs continue to be based on limited evidence, and survival...
3.
Castinetti F, Maia A, Peczkowska M, Barontini M, Hasse-Lazar K, Links T, et al.
Endocr Relat Cancer
. 2017 Jun;
24(8):L63-L67.
PMID: 28649091
No abstract available.
4.
Perakakis N, Flohr F, Kayser G, Thomusch O, Parsons L, Billmann F, et al.
Hormones (Athens)
. 2016 Jan;
15(1):113-7.
PMID: 26732163
Background: Multiple endocrine neoplasia type 1 (MEN1) is an autosomal-dominant hereditary disorder associated with the development of endocrine tumors due to reduced expression of the tumor suppressor protein menin. Recent...
5.
Meyer S, Neeff H, Thomusch O, Strate T, Tittelbach-Helmrich D, Hopt U, et al.
Pancreas
. 2015 Sep;
44(8):1245-51.
PMID: 26390417
Objectives: Ischemia/reperfusion injury (IRI) of the pancreas is a serious complication following pancreatic transplantation and hemorrhagic shock. The present study was designed to investigate the influence of the potent mammalian...
6.
von Dobschuetz E, Leijon H, Schalin-Jantti C, Schiavi F, Brauckhoff M, Peczkowska M, et al.
Endocr Relat Cancer
. 2015 Jan;
22(2):191-204.
PMID: 25595276
The precise diagnosis of thyroid neoplasias will guide surgical management. Primary thyroid paraganglioma has been rarely reported. Data on prevalence, immunohistochemistry (IHC), and molecular genetics in a systematic series of...
7.
Schulz K, Sommer O, Jargon D, Utzolino S, Clement H, Strate T, et al.
J Surg Res
. 2014 Oct;
193(2):831-40.
PMID: 25277359
Background: Breakdown of the intestinal barrier is a driving force of sepsis and multiple organ failure. Radical scavengers or cytokine inhibitors may have a therapeutic impact on intestinal failure. Therapeutic...
8.
Castinetti F, Qi X, Walz M, Maia A, Sanso G, Peczkowska M, et al.
Lancet Oncol
. 2014 Apr;
15(6):648-55.
PMID: 24745698
Background: The prevention of medullary thyroid cancer in patients with multiple endocrine neoplasia type 2 syndrome has demonstrated the ability of molecular diagnosis and prophylactic surgery to improve patient outcomes....
9.
Bausch B, Wellner U, Bausch D, Schiavi F, Barontini M, Sanso G, et al.
Endocr Relat Cancer
. 2013 Oct;
21(1):17-25.
PMID: 24169644
A third of patients with paraganglial tumors, pheochromocytoma, and paraganglioma, carry germline mutations in one of the susceptibility genes, RET, VHL, NF1, SDHAF2, SDHA, SDHB, SDHC, SDHD, TMEM127, and MAX....
10.
Neeff H, Sommer O, Meyer S, Tinelli A, Scholtes M, Hopt U, et al.
Pancreas
. 2012 May;
41(7):1105-11.
PMID: 22617706
Objectives: Reason for the unsuccessful use of antioxidants in transplantation might be the unknown kinetics of reactive oxygen species (ROS) release. In this study, we compared the kinetics of ROS...